Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Schrödinger FY 2024 Software Revenue Growth 6%-13%, Drug Discovery Revenue $30M-$35M, Software Gross Margin Slightly Lower Than 2023, Operating Expense Growth 8%-10%, Cash Used for Operating Activities Above 2023 Levels, Q3 Software Revenue $32M-$34M

Author: Benzinga Newsdesk | July 31, 2024 04:14pm

Posted In: SDGR